Skip to content

Using a Mobile App to Improve Medication Adherence and Reduce Relapse in Schizophrenia

The Effect of a Mobile Application–Based Care Program on Treatment Adherence and Relapse Rate in Patients with Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251030067827N1
Enrollment
50
Registered
2026-01-29
Start date
2026-01-21
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizopherenia.

Interventions

Intervention 1: intervention group : the first stage : at this stage and before the intervention by mobile application , the questionnaire of adherence to treatment and relapse of the disease will be

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: No prior participation in similar educational sessions Diagnosis of schizophrenia confirmed by a physician Patients with schizophrenia or their family members Possession of a smartphone with an Android operating system Ability to use a mobile phone and educational software

Exclusion criteria

Exclusion criteria: History of participating in training sessions Inability to use mobile phones and educational software for patients with schizophrenia or their families Not having a smartphone with Android operating system

Design outcomes

Primary

MeasureTime frame
The impact of mobile application-based care on adherence to treatment and relapse in people with schizophrenia. Timepoint: One month and three months after training. Method of measurement: Medanlou Treatment Compliance QuestionnaireK, Fiesbein, and Opler Disease Recurrence Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Norozpour

Islamic Azad University

fatemehnorozpourh@gmail.com+98 45 3248 2763

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026